Presentation The Structural Heart Disease Summit 2018 Percutaneous Subaortic Membrane Resection Using Radiofrequency Energy for Severe Congenital Subaortic Stenosis Due to a Discrete Membrane Presenter: Juan F. Granada, Martin B. Leon, Mehul Patel June 22, 2018
News Conference News The Structural Heart Disease Summit 2018 High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense? Michael O'Riordan June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Keynote Lecture #2: Useful and Evolving Biomarkers in Aortic Stenosis and TAVR - Current Status and Future Directions Presenter: Brian R Lindman June 22, 2018
Presentation The Structural Heart Disease Summit 2018 A Clinical Algorithm for Diagnosing and Managing Patients With Low-Flow, Low-Gradient Aortic Stenosis Presenter: Howard C. Herrmann, Allan Schwartz June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Contemporaneous Transcatheter Heart Valve Replacement in Native Aortic and Mitral Valve Stenosis Presenter: Isaac George, Christopher U. Meduri, Marcus R. Burns June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Multisociety Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Useful Guide for Clinical Decision-making? Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Linda D. Gillam June 21, 2018
Presentation The Structural Heart Disease Summit 2018 The Underdiagnosis of Aortic Stenosis: A Novel Approach Using Machine Learning to Improve Acquisition and Interpretation of Echocardiograms Presenter: Randolph P. Martin, Mark J. Russo June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Once the Cycle of Low-Risk Studies is Completed, Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis Presenter: Allan Schwartz, Stephan Windecker, Michael J. Reardon June 21, 2018
Presentation The Structural Heart Disease Summit 2018 NOTION 1 - Five-Year FU and Notion 2 - Young & Low-Risk Presenter: Lars Sondergaard June 21, 2018
Presentation The Structural Heart Disease Summit 2018 UK All-Comers Presenter: Neil E. Moat June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Evolut R Low-Risk Presenter: Jeffrey J. Popma June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Subtotal Left Main Occlusion Two Days After Transcatheter Aortic Valve Replacement in Severe Bicuspid Aortic Stenosis Presenter: Howard C. Herrmann, Fabian Nietlispach, Futoshi Yamanaka, MD June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Partner 3 Low-Risk Presenter: Martin B. Leon June 21, 2018
Presentation The Structural Heart Disease Summit 2018 An Introduction to the WATCH-TAVR Trial Combining TAVR and LAAC Presenter: Amar Krishnaswamy June 21, 2018
Presentation The Structural Heart Disease Summit 2018 European Perspectives and Updates From a Randomized Trial Combining TAVR and LAAC Presenter: Fabian Nietlispach June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Pharmacotherapy Considerations Trials and Practical Clinical Recommendations Presenter: George D. Dangas June 21, 2018
Presentation The Structural Heart Disease Summit 2018 A Growing Conundrum: Coronary Access After TAVR Technical Tips and Tricks Presenter: James B. Hermiller Jr June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Management of Coronary Disease in AS Patients: Important Treatment Considerations (When to Consider CABG, Timing of PCI and TAVR, and Completeness of Revascularization) Presenter: Torsten P. Vahl June 21, 2018
Presentation The Structural Heart Disease Summit 2018 The Role of MitraClip After TAVR: A Case-Based Tutorial (Who, When, and How) Presenter: Hüseyin Ince June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Clinical Decision-Mmaking in AS and MR Patients: Choosing the Best Patients for Multivalve Interventions Presenter: Anita Asgar June 21, 2018